New Mexico Gov. Michelle Lujan Grisham signed the Medical Psilocybin Act, making it the third state in the country to legalize access to psilocybin. Green Market Report...
Colorado has now licensed its first psychedelic healing center since passing Proposition 122, called The Center Origin. “We are honored to lead the way in bringing...
Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) reported a net loss of $4.97 million for 2024 while the botanical psychedelic drug developer expanded its clinical...
HOPE Therapeutics, an interventional psychiatry network wholly owned by NRx Pharmaceuticals (Nasdaq: NRXP), today announced it was buying Dura Medical per the previously announced non-binding letter of...
Florida-based psychedelics firm Enveric Biosciences (NASDAQ: ENVB), which is still in the pre-revenue stage, this week reported a $9.5 million net loss for 2024, down from...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) said Friday it’s made some inroads with its financials in 2024, removing its going concern designation as...
Relmada Therapeutics (Nasdaq: RLMD) announced Thursday it was shifting away from its previous focus on depression treatments and psychedelics, after acquiring two new Phase 2 drug...